Topic: Therapeutics

Dr. Peter Hotez expressed concern that canceling mRNA contracts will chill pharmaceutical investment and disrupt research into cancer immunotherapeutics. He revealed that many of these federal contracts were "advanced purchase" agreements, suggesting the financial impact on companies is a primary driver of the current media backlash.

Dr. Peter Hotez appeared on MSNBC to defend the National Institutes of Health (NIH) and the long-term research that led to mRNA vaccines. Hotez argued that the technology is now being pivoted toward cancer therapeutics, specifically for pancreatic and breast cancer. He also warned of future pandemic threats from the H5N1 bird flu virus, emphasizing that continued federal funding is essential for developing new vaccine strategies.

The pharmaceutical industry is bracing for potential price negotiations under the Inflation Reduction Act, with some analysts suggesting Donald Trump's proposals could be more disruptive to the industry than Joe Biden's. Meanwhile, Viking Therapeutics has emerged as a major competitor in the weight loss drug market, reporting positive results from clinical trials. The discussion highlights the lack of focus on diet and lifestyle in the national conversation about obesity.

The Chief Public Health Officer of Ontario acknowledged a 1 in 5,000 risk of myocarditis for young males receiving mRNA vaccines, suggesting a risk-based approach for healthy 18-year-olds. The official referred to the vaccine as a "therapeutic" rather than a "biologic." The hosts compare these health risks to other statistical causes of death, such as gun violence and accidents.

Dr. Maria Van Kerkhove of the WHO officially announced Omicron as a variant of concern. The discussion focuses on her use of the term "countermeasures" and whether the availability of therapeutics legally impacts the Emergency Use Authorization status of vaccines.

A study published in JAMA estimates that over 80% of American adults now possess COVID-19 antibodies, a figure traditionally associated with herd immunity. Big Pharma companies like Pfizer and Merck are now shifting focus toward oral therapeutics, such as a "COVID pill," to manage the virus long-term.

Former New York Times reporter Alex Berenson was indefinitely suspended from Twitter after tweeting that the COVID-19 vaccines do not stop infection or transmission. Berenson argued the shots should be viewed as therapeutics with limited efficacy and "terrible side effect profiles." His removal is cited as an example of extreme platform censorship regarding vaccine skepticism.

After a video of his treatment protocols went viral, Dr. Peter McCullough saw the content removed by YouTube for violating community terms. This event led to a call from the US Senate, as stakeholders in Washington were looking for academic figures to step forward regarding outpatient care. He criticizes the "therapeutic nihilism" of the current medical response.

Executive Producer Sir Onymous shared his experience traveling internationally without a COVID-19 vaccine by relying on PCR tests. He emphasized the importance of existing therapeutics like Ivermectin for those choosing to navigate global travel while avoiding the mandatory vaccination push.

Saudi Arabia has reportedly approved therapeutic protocols for outpatients involving hydroxychloroquine and zinc. Ivermectin is also being discussed as a potential alternative treatment. These off-patent drugs are being explored globally as low-cost options for managing the virus.

Dr. Anthony Fauci announced that the NIH is sponsoring ten new clinical trials for potential COVID-19 therapeutics. These trials aim to determine the safety and efficacy of various candidates for use as both treatment and prophylaxis, with results expected by the following winter.

Dr. Drew Pinsky walks back previous optimistic comments about the coronavirus, now urging the public to follow Dr. Anthony Fauci's directives. Pinsky recalls his time in the "Fauci army" during the 1980s AIDS epidemic, noting that while early death predictions were exaggerated, therapeutics eventually turned the disease into a manageable condition. He expresses faith that American innovation will similarly solve the current pandemic.

NPR reports on the criminal conviction of executives from Insys Therapeutics for a nationwide scheme to bribe doctors to prescribe the opioid painkiller Subsys. The trial revealed that the company targeted "pill mills," paid doctors sham speaking fees, and even used an exotic dancer as a sales rep to influence prescriptions. This case marks a significant shift as executives were charged with racketeering conspiracy rather than facing only civil fines.

Federal prosecutors have charged executives from Insys Therapeutics, including founder John Kapoor, for a scheme involving kickbacks to doctors who prescribed the fentanyl spray Subsys. The company allegedly used "speaker programs" and hired doctors' relatives as bribes to encourage off-label prescriptions. The lack of mainstream media coverage on this specific pharmaceutical scandal is noted.

Clinical trials using MDMA (Ecstasy) to treat Post-Traumatic Stress Disorder (PTSD) are showing positive results in controlled therapeutic settings. The FDA is overseeing studies where soldiers and other trauma survivors use the drug to facilitate therapy. One host jokes about having PTSD to justify trying the substance, while the other warns about the potential for brain damage.